Sector
Digital Detection & Diagnosis
Business Overview
Scopio Labs Ltd., a Tel Aviv-based start-up founded in 2015, is changing the field of clinical diagnostics as we know it through its Machine Learning-based digital microscopy technology.
Location
Israel
Milestones since Aescuvest Investment
FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization. Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform.
Funding Start
2022
Short Description
Revolutionizing diagnostic procedures by providing end-to-end digital cytology solutions thereby helping clinics of all sizes embrace digital innovation and unlock diagnostic insights.
Employee Count
85
Management
Itai Hayut, Erez Na'aman, Iris Getz, Guy Nathanzon
Round at time of investment
Series C

We are excited to share some very important milestones, that Scopio Labs was able to reach in recent weeks: 1. FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization Read the full announcement here: https://www.prnewswire.com/il/news-releases/scopio-labs-awarded-fda-clearance-for-high-throughput-hematology-digital-cell-morphology-platform-replacing-microscopes-with-digitization-301564972.html 2. Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform We are excited to share that Beckman Coulter and Scopio Labs have entered into a worldwide distribution partnership. “It is an honor to partner with Beckman Coulter, the pioneers of automated hematology testing and a known industry innovator, to accelerate the digital transformation of hematology…